A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)

NCT03933215 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Cladribine

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]